Market by Product Type, Application, and Country Outlook | Forecast 2022-2028
Based on Triton’s research
report, the medical enzymes market in Latin America is expected to witness
growth at a compound annual growth rate
of 7.27% during the forecast period 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries examined in the region are:
•
Brazil
•
Mexico
•
Rest of Latin America
In
Latin America, Brazil captures the majority of shares in the medical enzymes
market. The market’s
growth can be attributed to the rising demand for non-harmful biological
catalysts. Additionally, the high prevalence of digestive abnormalities and
increasing demand for effective pharmaceutical products are increasing the
demand for enzymes. The region accounts for around 3.5% of the global
pharmaceutical sector. As a result, the developing pharmaceutical sector is
anticipated to support the growth of the medical enzymes market over the
forecast period.
Brazil’s pharmaceutical sector has developed
significantly over the past few years. In 2020, the pharmaceutical industry’s
value amounted to around $21 billion. Moreover, healthcare spending witnessed a
surge, supporting the industry’s growth. Other than this, the increasing demand
for processed and packaged food products has increased the demand for enzymes,
such as carbohydrase, lipases, and others. Therefore, as stated above, these
factors are expected to propel the medical enzymes market on a growth path.
Furthermore, the country has witnessed a
significant rise in chronic non-communicable diseases over the years, becoming
a major cause of death. This has ultimately soared the demand for medical
enzymes to treat various conditions. Thus, these are another set of factors
driving the Brazilian medical enzymes market.
The medical enzymes are widely used as
therapeutics, drug targets, and biomarkers. They majorly help detect changes in
the substrate concentrations, revealing physiological disturbances. In recent
years, enzymes have been widely adopted in biomedical research, backed by
technological advancements and R&D activities. The market’s growth is assessed based on application and product type.
The application section includes biomedical research, disease treatment,
diagnostic tools, and other applications.
Some
of the leading companies in the medical enzymes market include BASF SE, Sanofi
SA, Novozymes, Roche Holding AG, Dupont, and DSM.
Sanofi SA is a leading healthcare company that
operates around 100 nations. The company operates through various business
segments, such as specialty care, vaccines, and general medicines.
Additionally, it holds a consolidated group of more than 290 affiliates. The
company’s operating segments include immunology, oncology, blood disorders,
diabetes, cardiovascular diseases, and neurology. Sanofi has operations across
multiple regions, including Latin America.
In June 2022, the European Commission approved
Sanofi’s Xenpozyme as the first and only enzyme replacement therapy to treat
non-central nervous system manifestations of ASMD.
Key deliverables of the report:
● Market CAGR during the forecasting years 2022-2028
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the medical enzymes market revenue growth in Latin America and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the LA medical
enzymes market’s growth during the upcoming years
Want to get specific
insights? Our team of analysts can customize this report based on your
preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA MEDICAL ENZYMES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE MEDICAL ENZYMES MARKET
2.2. KEY
INSIGHTS
2.2.1. ADVANCEMENTS
IN ENZYME ENGINEERING
2.2.2. INCREASED
DEMAND IN THE PHARMACEUTICAL SECTOR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. PRICE
2.4.2. QUALITY
2.4.3. USAGE
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.7.1. RESEARCH
AND DEVELOPMENT
2.7.2. OPERATIONS
2.7.3. OUTBOUND
LOGISTICS
2.8. KEY
MARKET STRATEGIES
2.8.1. MERGERS
& ACQUISITIONS
2.8.2. PRODUCT
LAUNCHES & DEVELOPMENTS
2.8.3. PARTNERSHIPS
& AGREEMENTS
2.8.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.9. MARKET
DRIVERS
2.9.1. RISING
INVESTMENTS IN RESEARCH AND DEVELOPMENT
2.9.2. RISING
AGING POPULATION AND OCCURRENCE OF CHRONIC DISEASES
2.9.3. INCREASING
APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY
2.10. MARKET
CHALLENGES
2.10.1. STRICT
REGULATIONS
2.10.2. SAFETY
CONCERNS WHILE HANDLING ENZYMES
2.11. MARKET
OPPORTUNITIES
2.11.1. RISING
HEALTH ISSUES AND GROWING AWARENESS
2.11.2. RISING
DEMAND FOR SPECIALTY ENZYMES
3. LATIN
AMERICA MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE
3.1. HYDROLASE
3.1.1. HYALURONIDASE
3.1.2. LYSOZYMES
3.1.3. OTHER
HYDROLASES ENZYMES
3.2. THROMBOLYTIC
ENZYME
3.2.1. STREPTOKINASE
3.2.2. UROKINASE
3.2.3. OTHER
THROMBOLYTIC ENZYMES
3.3. DIGESTIVE
ENZYME
3.3.1. LACTASE
3.3.2. L-ASPARAGINASE
3.3.3. OTHER
DIGESTIVE ENZYMES
3.4. ENDONUCLEASE
3.4.1. BENZONASE
3.4.2. OTHER
ENDONUCLEASES
4. LATIN
AMERICA MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION
4.1. DISEASE
TREATMENT
4.2. DIAGNOSTIC
TOOLS
4.3. BIOMEDICAL
RESEARCH
4.4. OTHER
APPLICATIONS
5. LATIN
AMERICA MEDICAL ENZYMES MARKET – COUNTRY OUTLOOK
5.1. BRAZIL
5.2. MEXICO
5.3. REST
OF LATIN AMERICA
6. COMPETITIVE
LANDSCAPE
6.1. BASF
SE
6.2. DUPONT
6.3. ROCHE
HOLDING AG
6.4. NOVOZYMES
6.5. DSM
6.6. SANOFI
SA
6.7. CODEXIS
6.8. ADVANCED
ENZYMES
6.9. AMANO
ENZYME
6.10. BBI
SOLUTIONS
6.11. THERMOFISHER
SCIENTIFIC INC
6.12. CPC
BIOTECH
6.13. NOVUS
6.14. BRAIN
BIOTECH AG
6.15. SEKISUI
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA MEDICAL
ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: APPLICATIONS
OF ENZYMES IN THE PHARMACEUTICALS INDUSTRY
TABLE 3: VENDOR
SCORECARD
TABLE 4: LIST OF
MERGERS & ACQUISITIONS
TABLE 5: LIST OF
PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 6: LIST OF
PARTNERSHIPS & AGREEMENTS
TABLE 7: LIST OF
BUSINESS EXPANSIONS & DIVESTITURES
TABLE 8: MEDICAL
APPLICATION OF VARIOUS ENZYMES
TABLE 9: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 11: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
TABLE 12: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 13: LATIN AMERICA MEDICAL ENZYMES MARKET,
BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
TABLE 14: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 15: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING
IMPACT ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 5: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 & 2028 (IN %)
FIGURE 7: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 10: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
FIGURE 11: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021 & 2028 (IN %)
FIGURE 12: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)
FIGURE 13: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)
FIGURE 14: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $
MILLION)
FIGURE 15: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
FIGURE 16: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021 & 2028 (IN %)
FIGURE 17: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)
FIGURE 18: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)
FIGURE 19: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 20: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
FIGURE 21: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY ENDNUCLEASE ENZYME, 2021 & 2028 (IN %)
FIGURE 22: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)
FIGURE 23: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $
MILLION)
FIGURE 24: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 25: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)
FIGURE 26: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)
FIGURE 27: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $
MILLION)
FIGURE 28: LATIN
AMERICA MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 29: LATIN
AMERICA MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 30: BRAZIL
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: MEXICO
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: REST OF
LATIN AMERICA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)